Dengue hemorrhage in a mouse model

Annals of the New York Academy of Sciences

Volumn 1171, Issue SUPPL. 1, 2009, Pages

  Wu Hsieh, Betty A ^a   Yen, Yu Ting ^a   Chen, Hsuen Chin ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

animal model; dengue virus; endothelial cells; hemorrhage; nitric oxide; reactive oxygen species; TNF

Indexed keywords

APOCYNIN; DENGUE VACCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BLEEDING; BLEEDING TIME; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; DENGUE; DISEASE SEVERITY; ENDOTHELIUM CELL; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INCIDENCE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; THROMBOCYTOPENIA; TUMOR ASSOCIATED LEUKOCYTE; VIRUS REPLICATION; ANIMAL; ARTICLE; BIOSYNTHESIS; BITES AND STINGS; BLOOD; C57BL MOUSE; DISEASE MODEL; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MOSQUITO; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY;

ANIMALIA; DENGUE VIRUS; MUS;

ANIMALS; APOPTOSIS; BITES AND STINGS; BLEEDING TIME; CELL DEATH; CULICIDAE; DENGUE HEMORRHAGIC FEVER; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; THROMBOCYTOPENIA; TUMOR NECROSIS FACTOR-ALPHA; VIRAL VACCINES;

EID: 70350459333     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05053.x     Document Type: Review

References (16)

1. Wilder-Smith, A. & E. Schwartz. 2005. Dengue in travelers. N. Engl. J. Med. 353: 924-932.
2. Chen,H.C. et al. 2007. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J. Virol. 81: 5518-5526.
3. Yen, Y.T. et al. 2008. Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J. Virol. 82: 12312-12324.
4. Cardier, J.E. et al. 2006. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium. 13: 335-340.
5. Grundmann, M. et al. 2008. Circulating endothelial cells: a marker of vascular damage in patients with preeclampsia. Am. J.Obstet. Gynecol. 198: 317.e1- 317.e5.
6. Erdbruegger, U., M. Haubitz & A. Woywodt. 2006. Circulating endothelial cells: a novel marker of endothelial damage. Clin. Chim. Acta. 373: 17-26.
7. Hober, D. et al. 1996. High levels of sTNFR p75 andTNF alpha in dengue-infected patients. Microbiol. Immunol. 40: 569-573.
8. Mackenzie, J.M., M.K. Jones & P.R. Young. 1996. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220: 232-240.
9. Lukacs, N.W. et al. 1995. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood 86: 2767-2773.
10. Avirutnan, P. et al. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 161: 6338-6346.
11. Maurer, M. & E. von Stebut. 2004. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 36: 1882-1886.
12. Mongkolsapaya J. et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9: 921-927.
13. Sangkawibha N. et al. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120: 653-669.
14. Gubler, D.J. et al. 1978. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27: 581-589.
15. Russell, P.K., S. Udomsakdi & S.B. Halstead. 1967. Antibody response in dengue and dengue hemorrhagic fever. Jpn. J. Med. Sci. Biol. 20(Suppl): 103-108.
16. Huang, J.-K. et al. 2000. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J. Gen. Virol. 81: 2177-2182.